secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immix Biopharma, Inc. (IMMX)
CIK:        0001873835
Form:       8-K
Filed at:   2023-08-22T23:59:59+00:00
Accession:  0001493152-23-029822
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Immix Biopharma raises $10M via private placement; appoints new director
------------------------------------------------------------------------

- Gross proceeds of ~$10M from sale of 3.24M shares at $1.94/share and 1.91M pre-funded warrants at $1.9399.
- Net proceeds of ~$9.55M; funds to be used for working capital and general corporate purposes.
- Pre-funded warrants exercisable at $0.0001/share, no expiration, with 19.99% blocker provision.
- Company to file resale registration statement within 30 days, seek effectiveness within 45 days.
- Yekaterina Chudnovsky appointed to board as independent director effective August 22, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1873835/000149315223029822/0001493152-23-029822-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1873835/000149315223029822/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-029822

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer